Nyxoah to Participate in Upcoming Investor Conferences
Mont-Saint-Guibert, Belgium – September 5, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in two upcoming investor conferences in New York City.
Olivier Taelman, Nyxoah's Chief Executive Officer, will deliver corporate updates at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023, at 1:30pm EST and the Baird Global Healthcare Conference on Wednesday, September 13, 2023, at 12:15pm EST. Webcasts of the presentations will be available on the Events section of Nyxoah's Investor ...